Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
CD38 and regulation of the immune response cells in cancer
Key Takeaways: Zepbound vs Wegovy Zepbound shows higher average weight loss: 22.5% vs 14.9% at maximum doses Zepbound (tirzepatide) acts on two hormone receptors, Wegovy (semaglutide) acts on one Both are FDA-approved specifically for chronic weight management Side effects similar but Zepbound may cause slightly more gastrointestinal issues Brand prices: Zepbound $1,069/month, Wegovy $1,349/month Compounded options: tirzepatide $349/month, semaglutide $199/month through TrimRx Insurance coverage inconsistent for both, many plans exclude weight loss medications Both require weekly self-injections using pre-filled pens Understanding Zepbound and Wegovy Both medications belong to a class called GLP-1 receptor agonists, though Zepbound technically goes beyond this single classification
Based on data from randomised controlled trials, you can expect to lose up to 5% of your weight in a month on semaglutide (Wegovy)
Tirzepatide (Mounjaro), a newer dual GIP/GLP-1 receptor agonist, is also available in the UK, though it may also cause gastrointestinal side effects
Keeping track of symptoms and checking in with your provider can make it easier to fine-tune your plan
